For the adjunctive treatment of seizures associated with LGS in adults and children,

Add BANZEL® for powerful, broad spectrum efficacy in total seizure reduction

  • 32.7% reduction of total seizures in the BANZEL® group vs 11.7% for placebo (P<0.002)1,2
  • References: 1. Glauser et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70(21):1950-1958. 2. BANZEL® (rufinamide) prescribing information, Eisai Inc.